Vladimir Lazar

12.2k citations

133 papers · 7.4k indexed · h-index 46

Molecular Biology top 1%
Oncology top 1%
Cancer Research top 0.5%
Immunology top 2%
Pulmonary and Respiratory Medicine top 2%

Co-authors: Philippe Dessen Razelle Kurzrock Maria Schwaederlé John Mendelsohn Richard L. Schilsky J. Jack Lee Ludovic Lacroix Guido Kroemer
Topics: Cancer Genomics and Diagnostics (35 papers)Lung Cancer Treatments and Mutations (17 papers)Cancer-related Molecular Pathways (10 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry The Journal of Experimental Medicine
Partner nations: France United States Netherlands

In The Last Decade

Vladimir Lazar

130 papers receiving 7.2k citations

Peers

Countries citing papers authored by Vladimir Lazar

Since Specialization

Citations

This map shows the geographic impact of Vladimir Lazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimir Lazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimir Lazar more than expected).

Fields of papers citing papers by Vladimir Lazar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimir Lazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimir Lazar. The network helps show where Vladimir Lazar may publish in the future.

Co-authorship network of co-authors of Vladimir Lazar

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimir Lazar. A scholar is included among the top collaborators of Vladimir Lazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimir Lazar. Vladimir Lazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA 2019 ·Cancer Immunology Research ·Kiran Kundu,Susmita Ghosh,Rhitajit Sarkar,Avishay Edri,Michael Brusilovsky,Orly Gershoni‐Yahalom,Rami Yossef,Avishai Shemesh,Jean‐Charles Soria,Vladimir Lazar,Ben‐Zion Joshua,Kerry S. Campbell,Moshe Elkabets,Angel Porgador	29
2	VEGF-A Expression Correlates with TP53 Mutations in Non–Small Cell Lung Cancer: Implications for Antiangiogenesis Therapy 2015 ·Cancer Research ·Maria Schwaederlé,Vladimir Lazar,Pierre Validire,Johan Hansson,(unknown),Jean‐Charles Soria,Yudi Pawitan,Razelle Kurzrock	96
3	Chk1 as a new therapeutic target in triple-negative breast cancer 2014 ·The Breast ·Laurence Albigès,Aïcha Goubar,Véronique Scott,Cécile Vicier,Céline Lefèbvre,Samar Alsafadi,Frédéric Commo,Mahasti Saghatchian,Vladimir Lazar,Philippe Dessen,Suzette Delaloge,Fabrice André,Virginie Quidville	46
4	Suppressor of cytokine signaling 1 modulates invasion and metastatic potential of colorectal cancer cells 2014 ·Molecular Oncology ·Muriel D. David,Cécile Naudin,(unknown),(unknown),Jack‐Michel Renoir,Vladimir Lazar,Philippe Dessen,Serge Roche,Jacques Bertoglio,Josiane Pierre	27
5	Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy 2013 ·Cancer Research ·Virginie Quidville,Samar Alsafadi,Aïcha Goubar,Frédéric Commo,Véronique Scott,Catherine Pioche‐Durieu,Isabelle Girault,Sonia Baconnais,Éric Le Cam,Vladimir Lazar,Suzette Delaloge,Mahasti Saghatchian,Patricia Pautier,Philippe Morice,(unknown),Stéphan Vagner,Fabrice André	75
6	Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: A clinical experience in 108 patients with metastatic breast cancer 2012 ·European Journal of Cancer ·Mónica Arnedos,Véronique Scott,Bastien Job,(unknown),Frédéric Commo,Marie Mathieu,(unknown),Catherine Richon,Mario Campone,Thomas Bachelot,Florence Dalenc,Philippe Dessen,Ludovic Lacroix,Vladimir Lazar,Jean‐Charles Soria,Suzette Delaloge,Fabrice André	18
7	Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC 2011 ·Clinical Cancer Research ·Luc Friboulet,(unknown),Frédéric Commo,Ken A. Olaussen,Stéphan Vagner,Julien Adam,Aïcha Goubar,Nicolas Dorvault,Vladimir Lazar,Bastien Job,Benjamin Besse,Pierre Validire,Philippe Girard,Ludovic Lacroix,(unknown),(unknown),Fabrice André,Jean‐Charles Soria	54
8	Transcriptional Analysis of an E2F Gene Signature as a Biomarker of Activity of the Cyclin-Dependent Kinase Inhibitor PHA-793887 in Tumor and Skin Biopsies from a Phase I Clinical Study 2010 ·Molecular Cancer Therapeutics ·Giuseppe Locatelli,Roberta Bosotti,Marina Ciomei,Maria Gabriella Brasca,Raffaele Calogero,Ciro Mercurio,Francesco Fiorentini,(unknown),Emanuela Scacheri,(unknown),Arturo Galvani,Enrico Pesenti,Thierry de Baère,Jean‐Charles Soria,Vladimir Lazar,Antonella Isacchi	11
9	miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death 2010 ·Cancer Research ·Lorenzo Galluzzi,Eugenia Morselli,Ilio Vitale,Oliver Kepp,Laura Senovilla,Alfredo Criollo,Nicolas Servant,Caroline Paccard,Philippe Hupé,Thomas Robert,Hugues Ripoche,Vladimir Lazar,Annick Harel‐Bellan,Philippe Dessen,Emmanuel Barillot,Guido Kroemer	239
10	Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array 2009 ·Clinical Cancer Research ·Fabrice André,Bastien Job,Philippe Dessen,Attila Tordai,Stefan Michiels,Cornelia Liedtke,Catherine Richon,Kai Yan,(unknown),Gilles Vassal,Suzette Delaloge,Gabriel N. Hortobágyi,W. Fraser Symmans,Vladimir Lazar,Lajos Pusztai	248
11	Abstract# 1788: In vitro and in vivo activity of vandetanib in a human medullary thyroid carcinoma model bearing a RETC634W activating mutation 2009 ·Cancer Research ·Sophie Broutin,Corinne Dupuy,Bernard Caillou,Vladimir Lazar,Andy Ryan,M. Schlumberger,J.M. Bidart	2
12	Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis 2009 ·The Lancet Oncology ·Fabrice André,Stefan Michiels,Philippe Dessen,Véronique Scott,Voïchita Suciu,Catherine Uzan,Vladimir Lazar,Ludovic Lacroix,Gilles Vassal,M. Spielmann,Philippe Vielh,Suzette Delaloge	46
13	Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines 2009 ·Oncogene ·Ken A. Olaussen,Frédéric Commo,Maximilien Tailler,Ludovic Lacroix,Ilio Vitale,Syed Qasim Raza,Catherine Richon,Philippe Dessen,Vladimir Lazar,Jean‐Charles Soria,Guido Kroemer	48
14	MYCN‐non‐amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S 2008 ·Molecular Oncology ·Jean Bénard,Gilda Raguénez,Audrey Kauffmann,Alexander Valent,Hugues Ripoche,V. Joulin,Bastien Job,Gisèle Danglot,(unknown),Thomas Robert,Marie‐José Terrier‐Lacombe,Agnès Chassevent,Serge Koscielny,Matthias Fischer,Frank Berthold,Marc Lipinski,Thomas Tursz,Philippe Dessen,Vladimir Lazar,Dominique Valteau‐Couanet	50
15	FOXO1 Regulates L-Selectin and a Network of Human T Cell Homing Molecules Downstream of Phosphatidylinositol 3-Kinase 2008 ·The Journal of Immunology ·Stéphanie Fabre,Florent Carrette,Jing Chen,Valérie Lang,Monique Sémichon,(unknown),Vladimir Lazar,Nicolas Cagnard,Anne Dubart‐Kupperschmitt,Marianne Mangeney,(unknown),Georges Bismuth	148
16	Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas 2008 ·Molecular Oncology ·Caroline Kannengiesser,Alan Spatz,Stefan Michiels,Alain Eychène,Philippe Dessen,Vladimir Lazar,Véronique Winnepenninckx,Fabienne Lesueur,Sabine Druillennec,Caroline Robert,Joost J. van den Oord,Alain Sarasin,Brigitte Bressac–de Paillerets	36
17	Microarray-Based Identification of Tenascin C and Tenascin XB , Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1 2007 ·Clinical Cancer Research ·Pascale Lévy,Hugues Ripoche,Ingrid Laurendeau,Vladimir Lazar,Nicolás Ortonne,Béatrice Parfait,Karen Leroy,Janine Wechsler,Isabelle Salmon,P. Wolkenstein,Philippe Dessen,Michel Vidaud,Dominique Vidaud,Ivan Bièche	43
18	A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib 2007 ·Cancer Research ·Thibault De La Motte Rouge,Lorenzo Galluzzi,Ken A. Olaussen,Yaël Zermati,Ezgi Tasdemir,Thomas Robert,Hugues Ripoche,Vladimir Lazar,Philippe Dessen,Francis Harper,Gérard Pierron,Guillaume Pinna,Natália de Souza Araujo,(unknown),Jean‐Pierre Armand,Tai W. Wong,Jean Charles Soria,Guido Kroemer	109
19	Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns 2002 ·British Journal of Cancer ·(unknown),Vladimir Lazar,Pierre Validire,Sophie Richon,(unknown),Vincent Laville,(unknown),Michel Barrois,(unknown),Thierry Poynard,G. Vallancien,Daniel Bellet	21
20	Levels of Plasma Testosterone in Ganders as Related to Egg Fertilization Rate 1984 ·Acta Veterinaria Brno ·Vladimir Lazar,(unknown),Jan Pícha,(unknown)	1

About Vladimir Lazar

Vladimir Lazar is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 133 papers that have together received 7.4k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (35 papers), Lung Cancer Treatments and Mutations (17 papers) and Cancer-related Molecular Pathways (10 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (2.1k citations) and Molecular Biology (4.1k citations). Vladimir Lazar has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Philippe Dessen, Razelle Kurzrock, Maria Schwaederlé, John Mendelsohn, Richard L. Schilsky, J. Jack Lee, Ludovic Lacroix, Guido Kroemer, Alexander M.M. Eggermont and Jean-Michel Bidart. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact